BA Sillah on Investing in Africa – (Podcast #9)

Logan Brock, MS2

On the most recent episode of the Penn HealthX podcast, we had the opportunity to speak with BA Sillah, an MD/MBA student who recently graduated from Wharton and the Perelman School of Medicine.

BA has a BA in Human Developmental and Regenerative Biology from Harvard. He researched bio-fabrication while at Harvard, then came directly to medical school after graduation. While at Penn, he worked as a Hospital Management Intern with the King’s Sierra Leone Partnership, an Operational and Investment Fellow at the Excelsior Group, where he evaluated venture investments on the African continent, and as an intern in the Specialty Pharmacy Department at Penn Medicine.

Some takeaways from our discussion:

1. Healthcare on the African continent varies widely by country

BA highlighted for us the disparities in healthcare between different nations in Africa, as each country uses a different strategy to guide the structure of its healthcare system. Some countries (Egypt, Tunisia, South Africa) have healthcare systems rivaling that of the United States, while others have fledgling systems that are still in early stages of development. As a result, the continent provides a myriad of examples of the various ways to set up a healthcare system, which will provide interesting insights about what types of healthcare systems can and cannot work effectively.

Another interesting challenge for healthcare in Africa is the changing socioeconomic landscape of the continent as countries develop and a growing middle class emerges. In the face of this change, healthcare systems are forced to decide whether to tailor their systems to serve the emerging middle class, who can generally afford to pay some of the cost of their healthcare, or whether to focus on providing care at low/no cost to the poorest citizens. As one example, Ghana provides National Health Insurance that covers all of its citizens – however, a private insurance market exists for the middle class who want to pay more for additional benefits not provided by the national plan.

2. Economically viable companies are more sustainable than charity care

Currently, charity care makes up an appreciable proportion of the medical care available on the African continent, particularly in less-developed nations. While charity care is provided with good intentions, it has unintended consequences. The provision of care by volunteers who only stay for a couple weeks leads to serious gaps in the continuity of care and a lack of long-term follow-up. Additionally, the myriad organizations that travel to provide charity care often do not share records – thus, it might be challenging or impossible for a patient to locate their own medical records. Conversely, investments in economically viable enterprises allows for the development of more sustainable healthcare delivery. If a company is of sufficient quality to attract venture investment and can provide a return on the invested capital, it indicates that the business model is sustainable. Instead of relying on providers to continue to donate time and money, these organizations will continue to exist for as long as they continue to generate a profit. Thus, venture investments in healthcare in the African continent help to ensure that a healthcare ecosystem develops that can sustain itself, instead of relying on transient volunteer care.

3. Investing in Africa requires wearing many hats

During BA’s internship at Excelsior, he saw firsthand the challenges facing healthcare companies on the African continent. As an example, he spoke with us about his work on a pharmacy company that was looking to expand into another African nation. He found that the initiative was fraught with challenges ranging from a complicated supply chain to a plethora of counterfeit medicine. He had to look beyond the company itself and work for increased regulation of pharmaceutical manufacturing to ensure the authenticity of medicines. In another project, he found that to help a diagnostic company succeed, they had to go beyond marketing and go directly to hospitals and medical schools to educate physicians on the use of ultrasound. As a result, the work BA performed to ensure the success of investments had positive benefits on the entire healthcare system.

We really enjoyed sitting down with BA to hear about his experience learning about and investing in the healthcare industry on the African continent. He showed us the ways that venture investments could lead to an independent and self-sustaining healthcare system and create unexpected positive benefits for the healthcare system. We’re excited to see what he does next!

– Logan is a second-year medical student at the Perelman School of Medicine. He is the co-VP of curriculum for Penn Health-X, an occasional co-host of the Penn HealthX podcast, and a contributor to the Penn HealthX blog. You can contact him at –

Eric Heil on Co-Founding RightCare Solutions, Studying Systems Engineering, and Reducing Readmissions (Podcast #8)

Ryan O’Keefe, MS2 –

On the most recent episode of the Penn HealthX podcast, I had the opportunity to speak with Eric Heil, who co-founded RightCare Solutions, a health-tech company that helped hospitals reduce readmissions rates and optimize post-acute care delivery. The company was acquired by Navi Health in 2015.

Kathy Knowles, a rock star at the Nursing School at Penn, was the other co-founder.

Eric has a BSE in Systems Engineering from Penn, and an MBA from the Wharton School as well. He played basketball at Penn, and even made it to the NCAA tournament twice in his career. After graduating, he took on numerous different jobs working at the intersection of business and healthcare which ultimately prepared him to found his own company.

Some takeaways from the discussion:

1. You don’t have to have a master plan – conviction will drive you in the right direction

Eric admitted that though he had an interest in making systems better, and the healthcare space more generally, he didn’t have a “master plan” for his career and life. In fact, he tended to go with his gut whenever he learned about something new and exciting that he could get involved with. For example, when he learned about the opportunities in venture capital, helping to advise companies and bring their products to market, he went to Domain Associates. When he discovered that his old thesis research at Penn was suddenly valuable because of new ACA regulations, he immediately contacted Kathy Knowles to see if she wanted to partner up and found RightCare.

Eric mentioned that when it comes to making changes in your line of work, the book Letters to a Young Entrepreneur by Ricardo B Levy helped him understand that you will feel a sense of “conviction” that guides you to new projects. Furthermore, sometimes you will just need to get lucky. Eric left Bear Stearns four weeks before the financial collapse in 2007 and 2008. Many (including his father) told him he was nuts to leave such a promising job, and yet he knew it was the right thing for him. Sometimes going with your gut can prove to be fortuitous – if Eric had planned on staying at Bear Stearns forever, he would have been hit with a large dose of reality. Remember not to stick too closely to a “master plan”.

2. Go to conferences and talk to people about your work and ideas

While listening to Eric’s story of founding RightCare, the thing that struck me most was the setting in which some of the initiating conversations happened. It was at the JP Morgan Healthcare Conference in 2011.  This really hit home for me just how important going to conferences to talk with other like-minded people thinking about the same types of problems you are. It was here that Eric learned about how he was essentially sitting on a goldmine of data because of the new ACA regulations.

It’s not only important to physically surround yourself with people working on exciting projects in your fields, but to also engage them and not be afraid to tell them what you do, and what you want. One thing I’m personally working on is how to properly promote myself. It’s often an uncomfortable thing, but it’s so crucial to let everyone know what it is that you want. You never know who is out there who has the connections or knowledge to help you out.

For those at Penn or in the local Philadelphia area, check out the annual Wharton Business in Healthcare Conference, and Penn HealthX Conference to meet students, faculty, and KOL’s working at the intersection of business and medicine.

Here are some interesting resources I found on how to market yourself at conferences:

3. Things Move Slowly in Healthcare – Change is Hard

 Entrepreneurs love sayings like “disrupt” and “fail forward”. While this often works in many tech fields, unfortunately things can be way more difficult in healthcare. Change is always harder than everyone expects. One reason for this is that when dealing with people’s healthcare and lives, you can’t afford to experiment and get things wrong. There is a strict process we must follow to ensure that all patients receive the highest quality of care, and any change to the way care is delivered undergoes intense scrutiny from many parties. Just think about the FDA, and how difficult it is to get drugs and medical devices approved. The same goes for healthcare technologies entrepreneurs are looking to implement in hospitals, like RightCare.

It’s important to recognize the difference between inertia that is properly built into the system to protect patients, and that which is there because of the status quo. Go through the proper channels, but don’t take no for an answer, or let one party out of the many you work with dictate everything you do, simply because you are afraid to speak up and push the process along. People skills will be very handy when dealing with such barriers.

4. It doesn’t have to be your idea

My favorite part of the RightCare story is that it wasn’t technically Eric’s idea. He got involved with his thesis at Penn after hearing about the opportunity from a professor. The data that was collected over the years which gave the company its value was mostly consolidated when Eric was off working at other jobs building other meaningful skills. Yet, because Eric felt conviction, saw the opportunities, and pulled the trigger, he was able to serve as the co-founder and CEO. It doesn’t have to be your idea! But if you have a skill-set to help drive the mission of the company forward, offer your time and brain – your two most valuable assets. Pay attention to the amazing opportunities all around you, and figure out how you can best contribute. You may stumble upon one of the greatest opportunities of your lifetime. Be prepared and speak up.


– Ryan is a second year medical student at the Perelman School of Medicine. He is the co-VP of curriculum for Penn HealthX, the co-host of the Penn HealthX podcast, and founder/editor-in-chief of the Penn HealthX blog. You can contact him at ryan.o’ –

Tim Carlon and Value Based Payments (Podcast #7)

Logan Brock, MS2

We had the chance to sit down with Tim Carlon, an MD/MBA student a few years ahead of us in medical school at Perelman. We got to speak about his passion, value-based payments. Tim taught Ryan and I about two models of value-based payments that are currently being piloted, accountable care organizations and bundled payments. He also told us about MACRA – a law that neither of us knew much (if anything) about before this conversation, which has huge implications for future physicians and how we will be paid.

Tim graduated from Duke University with a degree in biomedical engineering. While he originally thought he would pursue a Ph.D., Tim chose to go to medical school so he could see the effects that his work had on patients more directly. During his time in medical school, Tim discovered a passion for making the healthcare system function more efficiently, and he viewed value-based payments as the best way to do this. Tim spent this summer at Cigna, where he worked on value-based reimbursement.

Some major takeaways from our conversation:

1.) Value-based payment models will allow us to (finally) align the incentives of doctors and patients

While many people believe doctors are paid for providing quality care, this has only recently become the norm. Until the last decade or two, not only were payments not tied to quality, but lower quality care could actually benefit a hospital financially. For example, if a patient had a complication following a procedure, the hospital could profit from both the initial episode of care and from the readmission to deal with the complication. Value-based payment models, once they’re set up correctly, will allow us to much more effectively incentivize physicians to improve patient outcomes.

2.) MACRA is the bill you’ve never heard of that will define how physicians are paid

MACRA, the Medicare Access and CHIP Reauthorization Act of 2015, barely received any of the hype that seems to surround healthcare legislation in recent years. This is because the bill primarily affects doctors, and has much less impact on patients. As future physicians, however, this law will literally govern how we are paid. In addition to many much-needed changes – such as eliminating the annual “doc fix” – but it also links payments to quality metrics that must be reported starting in 2017. Over the next decade, performance on quality metrics will adjust payments up or down by up to 9%. This means a hospital or provider group with top scores on quality metrics could be paid nearly 20% more than one with the worst quality scores, for doing the same volume of work!

3.) He offered two suggestions for medical students to thrive in a value-based world

First, and not surprisingly, every medical student should become the best physician that they can. By working hard throughout medical school and residency, we can learn to provide great care to our patients. Second, and less obviously, we should be willing to be evaluated for the quality of our care, learn from these metrics, and identify areas to improve. As quality measures are rolled out, we will have the opportunity to self-reflect and identify areas where we can become even better doctors.


The metrics by which quality is measured will constantly be evaluated and improved, and physicians will have the opportunity to contribute to these discussions. In the long term, this system should allow us to (finally) pay for high-value medical care. The result could be a shift from “fee-for-service” to “fee-for-value.”


We’re excited to see where Tim goes next, and watch the value-based payment models that he is working on improve the US medical system!

– Logan is a second year medical student at the Perelman School of Medicine. He is the co-VP of curriculum for Penn Health-X, an occasional co-host of the Penn HealthX podcast, and  a contributor to the Penn HealthX blog. You can contact him at

How to Rate the Podcast!

You can rate the Penn Health-X Podcast either on iTunes, or on the Podcast App on an iPhone. If Android users are having trouble figuring out how to rate us, please email and we will do our best to help you out!

Ratings really help us with feedback to make the show better, and helps other people find the show as well! With enough support, we may even get onto a list of top podcasts! We need your help! It only takes a few minutes, tops!

For iTunes:

  1. Open iTunes on your computer.

  2. Go to the “Store” tab in the top-center of iTunes. Screen Shot 2017-09-05 at 10.11.55 AM

  3. In the search bar in the top right, type in “Penn HealthX”

  4. Click on the Picture of our logo in the bottom left corner. Screen Shot 2017-09-05 at 10.13.34 AM

  5. Click on the “Ratings and Reviews” tab on the next screen.Screen Shot 2017-09-05 at 10.15.56 AM

  6. In that tab, click on “Write a Review”Screen Shot 2017-09-05 at 10.19.13 AM

  7. Choose a unique nickname – doesn’t matter what, but you may want to not give any personal identifiers, as this is what will be shown above your review!

  8. Choose how many stars. 5 is the best, so hopefully you think the podcast is worthy of 5’s or 4’s!

  9. Give the review a title – this can be anything, but is usually a short sentence summary of your overall review.

  10. You can go more in depth with the actual review – tell us what you like, what you want to see us improve on, etc. Be honest!

  11. Hit “Submit!”

  12. You may not see it go through, or show up immediately. Most comments are screened, but you should see it within a few hours at the latest. If you hit “write a review” again, it should show your review is already there (meaning it submitted successfully), and you can change it if you want.


Podcast App – iPhone

  1. (If you don’t already have the podcast app) In the app store, tap the “search” button at the bottom right. Type in “podcast” into the search bar at the top.


  2. Click “Get” (where the above image says “open”), and the app will download automatically.

  3. Open the podcast app, and hit the search button in the bottom right corner.


  4. Type in “Penn HealthX”.

  5. Click on our logo in the bottom left corner.


  6. Click on the “reviews” tab.

  7. Click on “write a review”


  8. Choose  unique nickname (with numbers) – this is what will display above your review!

  9. Choose a star rating – hopefully 4 or 5!

  10. Give the review a title – usually a short sentence summary of your review.

  11. Type out your review.

  12. Hit “send” in the top right corner.

  13. You may not see it go through, or show up immediately. Most comments are screened, but you should see it within a few hours at the latest. If you hit “write a review” again, it should show your review is already there (meaning it submitted successfully), and you can change it if you want.



Thanks for taking the time to review The Penn Health-X Podcast! We really appreciate the support and feedback! We’re looking forward to making more great content!


The Biomedical Entrepreneurship Network (BEN) and Scientista Foundation – Gregg Khodorov and Julia Tartaglia (Podcast #6)



Ryan O’Keefe, MS2

We are always overjoyed to meet students at other schools who share the same goals and ideals of Health-X. I met Gregg Khodorov at the Wharton Business in Healthcare Conference, and we knew we had to c

ollaborate. He then introduced me to Julia Tartaglia, his fellow co-president of BEN, the Biomedical Entrepreneurship Network, out of the Rutgers Robert Wood Johnson Medical School. I spoke with both them over Skype about their backgrounds, interests, and what they hope to accomplish with BEN. We were also able to talk about the Scientista Foundation, which is an organization co-founded by Julia to address the “leaky pipeline” which shows that women are more likely to drop out of STEM programs and careers.

Some takeaways from our conversation:

1.) Entrepreneurship is like running a club, but you get paid for it

While starting a company is no easy feat, if you have any experience starting something from the ground-up, you understand how many barriers and unforeseen challenges you will ultimately have to address. Many of those in med school have at one point or another been a leader of a club or organization.

In every circumstance, such experiences are learning opportunities in management, leadership, and communication. At its core, being an entrepreneur is a lot like starting or leading a club in college. You start to realize that you have to learn on the job, adapt, and just give things a try. You will probably have no idea what you are doing – no one really does. The main difference is that as an entrepreneur, you get to make some money!

2.) There will be many barriers to starting something new, so you need to surround yourself with people who will help lift you over those barriers

Again, it’s no secret that starting organizations or companies takes a lot of work. However, what may be surprising is how many little things add up, and how they always end up taking way longer than you expect. It can quickly become overwhelming for one person to take on all of the responsibilities. There just isn’t enough time or energy. That’s where your team comes in.

For example, if your goal is to start a group on campus, it’s crucial to find other students, faculty, and administration members who see the value in your idea, and want to genuinely help. Surrounding yourself with a team that can both help spread out the work and hold you accountable will keep you moving forward.

When it comes to writing this blog, and making new episodes of the podcast, it was hard for me to find motivation initially while it was still just an idea in my head. There were so many little things to do and decide on, that when added up seemed insurmountable in their totality. Once I pitched the idea to the Health-X board, and some of Penn Med’s administration, I knew I had to follow through. It wasn’t just on me anymore, I had to be accountable to others.

3.) People will rarely understand your vision, but it may seem obvious and downright necessary in hindsight

Julia shared that when she initially approached others about her idea to start a group specifically for women in the STEM fields, many didn’t understand why it was necessary. Today, such naivety is borderline laughable. The inequalities and difficulties for women in such fields is now understood to be a widespread issue. When it comes to truly visionary ideas or products, the sad reality is that most other people will tell you it’s dumb or useless. That’s part of what it means to be revolutionary and ahead of your time – if it was obvious to others, someone would have done it already. Thus, when you do find those who understand you and your vision, you need to capitalize on that and include them in your mission.

4.) Starting a Health-X or BEN-like organization at your school is 100% do-able, as administrations are beginning to see the draw and value of innovation

While we are incredibly proud of what we’ve accomplished at Health-X in only a few short years, we recognize that the group was born at an institution that already had a strong foundation of crossover in the business, entrepreneurship, and healthcare worlds. There were already some other groups – primarily at Wharton – that had similar niches, but were not specifically tailored to med students.

Not every school across the country offers programming focusing on the intersection of business and medicine – and many administrators and clinicians still argue that such projects and endeavors are antithetical to clinical practice and putting patients first. After all, if you want to start a company, just get your MBA, right? Why get the medical degree at all? You should make room for people who want to be PCP’s or practice full time. Some believe this, and you need to understand that.

There will undoubtedly be some inertia, or confusion as to why med students are interested in management, entrepreneurship, and technologies. Keep in mind that some of the most senior clinicians and deans of the best institutions in the world went to medical school in the 60’s and 70’s, before many of the current standard of care medicines and technologies were even created! However, the zeitgeist is shifting rapidly – innovation is in (helped along by shows like Shark Tank, and podcasts like How I Built This) and schools are beginning to realize that new students want to see such offerings available. If it will help draw the best and brightest students, the schools will adapt – and you can be at the front of the charge!

Please contact us at Health-X (, or Gregg or Julia at BEN, if you want help establishing your own group on your campus. It can start with just one passionate student. Why not you?


– Ryan is a second year medical student at thePerelman School of Medicine. He is the co-VP of curriculum for Penn Health-X, the co-host of the Penn Health-X podcast, and founder/editor-in-chief of the Penn Health-X blog. You can contact him at ryan.o’ –

Nora Becker – The ACA, Women’s Health, and Contraception (Podcast #5)

Though Nora is now officially Dr. Becker, and has begun her internship at Brigham and Women’s, I had the opportunity to sit down with her while she was still a student at Penn. We had a great conversation about her research, which focused on the Affordable Care Act’s impact on women’s health. We went more in depth on a specific project looking into the ACA’s effect on women’s overall contraceptive usage.  This work was tweeted out by then President Barack Obama, which led to a media frenzy, and almost immediately made her work political.

Nora received her bachelors in Public Policy from Pomona College in 2007. Before going to Penn for med school, she deferred a year to work as a staffer on Barack Obama’s presidential campaign, and as an administrative assistant in the White House.

Some major takeaways from our conversation:

1.) Though uncommon, you can do your MD/PhD in something outside of basic science

When I think of MD/PhDs, I immediately assume the person is doing biomedical research. However, it is definitely possible (at some schools) to do your PhD in many other fields! As you will probably want to have it relate back to healthcare, healthcare economics is an increasingly important field for future physicians to appreciate! There are plenty of other ways to delve into that world without dedicating 3-4 extra years of research – such as a master’s degree, certificate, or by getting involved with a specific research project. But if you are really drawn to the field, the PhD is an option!

2.) Research gives you the rare opportunity to be genuinely ambivalent

I loved Nora’s attitude when she said that if the ACA was repealed, she would study the effects of it being repealed. I personally had been interested in studying and working in health policy, but the 2016 election really made me question whether to get involved or not. It had less to do with politics as much as my realization of the transient nature of policy, the high failure rate in passing legislation, and that by picking a side, half the country will immediately decide that you are wrong. Perhaps it’s a cynical view, but I would have expected that Nora would have been terrified that her research, which she spent years on, would become essentially irrelevant if the ACA were to be repealed.

Instead, Nora maintained her positivity and insisted she would adapt. Though she also works in advocacy and has policies she would like to see implemented, when it comes to research, there will always be questions to pose and answers to discover. This is the benefit of being a researcher, I suppose. If you’re on the sidelines, you have the benefit of studying something regardless of what happens in policy. If you only work trying to get specific legislation passed, or in advocacy for specific cause, you are far more likely to be disappointed, or feel like you aren’t making progress. Combining research with advocacy may be best for your overall sanity and morale. This in mind, it’s impossible to be unbiased and have no opinions on health policy matters, but as a researcher you are (hopefully) able to put those feelings aside, and search for the truth. However…

3.) Explaining complex research to the public and media outlets can be frustrating, especially when it becomes politicized

Nora was both blessed and cursed when President Obama tweeted out her research. While it is incredible to see people take an interest in your work, it can be equally frustrating to watch as people either misinterpret it, or use it for their own political messaging. Sometimes this can’t be avoided – media coverage usually necessitates explanations for the layman. Yet, so much can be lost in translation when you simplify the language of your work, or distill it down to 500 words. After all, you can’t sit down with every reader and talk them through your paper, and the complicated economic analyses you performed. This is true for most research, but especially for biomedical research – media outlets LOVE blowing findings out of proportion. That’s why we need websites like – to keep a leash on irresponsible healthcare reporting.

The best we can do if we are fortunate enough that our work draws widespread attention is to control our own messaging, but understand that some things are simply out of our control.


You can find some of Nora’s work listed on PubMed here.

I’m excited to find out what Nora researches next – there are some whispers of looking into opioid usage. We’ll just have to wait and see!


– Ryan is a second year medical student at the Perelman School of Medicine. He is the co-VP of curriculum for Penn Health-X, the co-host of the Penn Health-X podcast, and founder/editor-in-chief of the Penn Health-X blog. You can contact him at ryan.o’ –

Dr. Debbie Kelly – Leaving Clinical Practice for Industry (Podcast #4)

Ryan O’Keefe, MS2

It was great to speak with Dr. Kelly more in-depth, after she came to speak for the Health-X seminar series. Before I jump into the major takeaways from our discussion, a quick background.

In medical school at Columbia, Dr. Kelly was choosing between orthopedics, endocrinology, and ophthalmology. After a rotation, she chose ophthalmology and did her residency in Atlanta. She then came to Penn where she jumped back and forth in a number of roles within the Penn network of hospitals. After 11 and a half years of practice, Dr. Kelly was put in touch with someone at GlaxoSmithKline who showed her all of the opportunities in pharma for those with an MD. She joined the company to help work on an ophthalmology drug which ended up not panning out. She then moved to the pharmacovigilance department at GSK where she was able to work on more than just ophthalmology drugs. Last year, she was contacted by a headhunter and was recruited to lead to pharmacovigilance department at Spark Therapeutics, where she is today.


I was struck by few things during our conversation.

1.) It’s not uncommon to be torn between many specialties, and in actuality, many doctors would be happy doing many different things!

From the vantage point of a first-year medical student, it was a breath of fresh air to know that many people have trouble narrowing down their choice of what residency to do. At places like Penn where we are fortunate enough to learn from those leading their respective fields, it can feel like all of the attendings and PI’s had a single calling which they knew of from birth. It’s hard to imagine rock stars like Carl June not knowing he wanted to go into immunotherapy research, and yet there was certainly a time and place where I’m sure that was a tough decision.

A generalist at heart, it’s tough to accept that I would probably be happy practicing many different types of medicine. Sometimes the medical training pipeline can make it seem like there is only one perfect fit for you, and it’s on your shoulders to find out which. Yet, the I reject the idea that I will find the perfect clinical match. In fact, we would do well to think of Dr. Kelly and how she chose ophthalmology not because it was the only thing she could ever see her doing, but because it felt right. While she was able to bring her expertise as an ophthalmologist to both GSK and Spark, she has had to develop many new skills, and continue to learn. Flexibility, and the ability to pick up new knowledge quickly are skills that will transfer well into any endeavor you take on. Be an expert, but don’t lose your adaptability.

2.) Those who choose to ultimately pursue opportunities outside of clinical practice may still really enjoy working with patients!

I’ve noticed there is a stigma that people who end up leaving clinical practice either don’t care about patients, or secretly (or not-so-secretly) disliked clinical practice. While this is undoubtedly true for some people, after talking with Dr. Kelly, it became clear that some leave clinical practice because they are ready to take on different challenges. Furthermore, if they end up working in other sectors of the healthcare space, they are able to bring a clinician’s perspective, and advocate on behalf of the patient experience. Dr. Kelly was drawn to GSK in part because she could improve the standard of care for many more patients by helping to develop an effective drug. Whether you are directly or indirectly benefiting the care of patients, you are an important part of the drug supply chain.

3.) All the flashy scandals aside, industry isn’t by default the “Dark Side”

I think Dr. Kelly put it best when she said that there are good and bad people who act accordingly in all facets of life. Are there selfish actors in the drug development world? Of course. But is the research community, or the clinical world only full of angels working solely for the greater good? No way – they just don’t have as much publicity and capital at stake.

It’s easy to point fingers and create simplistic bad guys in our minds when we think about the monster that is the U.S healthcare system. The gene therapies at Spark, where Dr. Kelly currently works, will undoubtedly cost tons of money – maybe even close to (or above) a million dollars. Yet they are potentially curative, one-time therapies for diseases with either no standard of care, or treatments that significantly reduce the patient’s quality of life. Even if you believe that the insurance industry or pharmaceutical companies are evil, money-hungry corporations, shouldn’t we want people like Dr. Kelly taking her experiences and passion for patient care into the conversation? Maybe you could be the voice for both doctors and patients at such companies, changing the discussion from the inside. With MD’s on the sidelines, I wouldn’t expect much to change on its own. Things are far from black or white, and I always try to remind myself when I frame problems within the system as having good guys and bad guys.

4.) Hopping off the clinical train can be tough, but you have to make sure you’re staying on for the right reasons

When deciding whether or not to pursue a new opportunity, or continue along on the path laid out before you, Dr. Kelly insists we must be critically self-reflective and determine whether we are afraid to make a change simply because of inertia. Pursuing opportunities and projects – especially those in the H-MET space, like starting a company, consulting, or working in hospital administration – often lead clinicians to leave practice, or only see patients part-time. This can be a harrowing decision, especially because after a number of years, clinical practice can be so comfortable in terms of income and lifestyle. It’s not always easy to determine whether we are scared to do something because of inertia, or because it’s a genuinely poor choice.

Dr. Kelly shared that she knew it was time to make a change when she couldn’t wait to tell her friends and family about the opportunity to work at GSK. Sometimes it’s something you just know. Other people will need to do an elaborate cost-benefit analysis and have long conversations with people who know them best before they decide to make a change. However it is you approach making tough decisions, be wary of turning down opportunities out of fear. You may look back and regret it.

– Ryan is a second year medical student at the Perelman School of Medicine. He is the co-VP of curriculum for Penn Health-X, the co-host of the Penn Health-X podcast, and founder/editor-in-chief of the Penn Health-X blog. You can contact him at ryan.o’ –